Structural biology of SARS-CoV-2: open the door for novel therapies

Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is the causative agent of the pandemic disease COVID-19, which is so far without efficacious treatment. The discovery of therapy reagents for treating COVID-19 are urgently needed, and the structures of the potential drug-target proteins i...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Weizhu, Zheng, Yanhui, Zeng, Xiaotao, He, Bin, Cheng, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8793099/
https://www.ncbi.nlm.nih.gov/pubmed/35087058
http://dx.doi.org/10.1038/s41392-022-00884-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8793099/
https://www.ncbi.nlm.nih.gov/pubmed/35087058
http://dx.doi.org/10.1038/s41392-022-00884-5

Ejemplares similares